Blogs

Blog post list

• 5 tips to help get your healthtech product to market, fast

  Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.

• Focusing on what matters most to the NHS

  For more than 25 years NICE has helped practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.

• Preparing for the next breakthroughs in liver disease treatments

  With no licensed treatments for MASH, a serious liver condition affecting 3 million in the UK, NICE has co-developed a framework with patients, clinicians, and industry to accelerate access to promising new medicines.

• Shaping the future of global health technology assessment

  Learn about our role in the new international Health Economics Methods Advisory (HEMA) and its ambitions to make a real difference to patients around the world.

• Same time decisions on licensing and value - what pharmaceutical companies need to know

  Learn how NICE and MHRA are launching an aligned pathway to accelerate patient access to medicines and provide a more efficient route for industry.